Boston, United States
Vida Ventures is a next-generation life sciences investment firm founded in 2017 by a group of scientists, physicians, entrepreneurs and investors passionate about building and funding breakthroughs in biomedicine. Together we form an independent, bold investment group bound together by a simple word – life. Our mission is to bring science to life and advance transformative biomedical innovations that have the potential to make a meaningful difference for patients. Vida has a bicoastal presence and currently manages approximately $1.8 billion.
40
Total Investments
31
Portfolio Companies
-
Exits
-
Industries
General Information
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Vida Ventures
Recent Investments (40)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series A | •••••• | Mar 2026 | |
| Series C | •••••• | Apr 2025 | |
| Late Vc | •••••• | Sep 2024 | |
| Debt Financing | •••••• | Aug 2024 | |
| Series A | •••••• | Jun 2024 | |
•••• ••••
|
Series B | •••••• | Apr 2024 |
|
•••• ••••
|
Series B | •••••• | Mar 2024 |
|
•••• ••••
|
Series C | •••••• | Sep 2023 |
|
•••• ••••
|
Series B | •••••• | Sep 2023 |
|
•••• ••••
|
Series B | •••••• | Aug 2023 |
Latest News
UCB pays up to $2.2bn for Candid Therapeutics, doubling down on T-cell engagers in autoimmune disease
Thenextweb · May 04, 2026
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
